GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wonbiogen Co Ltd (XKRX:307280) » Definitions » Debt-to-Equity

Wonbiogen Co (XKRX:307280) Debt-to-Equity : 0.21 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wonbiogen Co Debt-to-Equity?

Wonbiogen Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩6,093 Mil. Wonbiogen Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩642 Mil. Wonbiogen Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩32,571 Mil. Wonbiogen Co's debt to equity for the quarter that ended in Mar. 2024 was 0.21.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Wonbiogen Co's Debt-to-Equity or its related term are showing as below:

XKRX:307280' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.34   Med: 0.16   Max: 0.35
Current: 0.21

During the past 6 years, the highest Debt-to-Equity Ratio of Wonbiogen Co was 0.35. The lowest was -0.34. And the median was 0.16.

XKRX:307280's Debt-to-Equity is ranked better than
50.86% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs XKRX:307280: 0.21

Wonbiogen Co Debt-to-Equity Historical Data

The historical data trend for Wonbiogen Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wonbiogen Co Debt-to-Equity Chart

Wonbiogen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial 0.16 -0.34 0.30 0.34 0.23

Wonbiogen Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.33 0.24 0.23 0.21

Competitive Comparison of Wonbiogen Co's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Wonbiogen Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wonbiogen Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wonbiogen Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Wonbiogen Co's Debt-to-Equity falls into.



Wonbiogen Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Wonbiogen Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Wonbiogen Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wonbiogen Co  (XKRX:307280) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Wonbiogen Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Wonbiogen Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Wonbiogen Co (XKRX:307280) Business Description

Traded in Other Exchanges
N/A
Address
56, 1 Gongdan-ro 5-gil, Gyeongsangbuk-do, Gumi-si, KOR
Wonbiogen Co Ltd is engaged in the manufacturing of medical supplies and instruments. Its product portfolio comprises Therasorb Algi Adhesive, Therasorb AD, Renoderm, Remscar Gel, Meditouch Liquid, and Meditouch Bend, among others.

Wonbiogen Co (XKRX:307280) Headlines

No Headlines